People
There has been something of a furor over reports in the German newspaper Welt am Sonntag that claimed the Trump administration offered a “billion dollars” for exclusive rights to a coronavirus vaccine in development by German company CureVac, “but only for the USA.”
Restricting face-to-face interactions with people will go a long way in limiting the spread of the virus.
Inside the U.S., the first clinical trial for a vaccine to the novel coronavirus that causes COVID-19 began today.
Arie Belldegrun, the co-founder and executive chairman of the board of Allogene, disclosed this weekend that he has been diagnosed with COVID-19. The pharma entrepreneur is in self-quarantine and is doing well.
Companies strengthen their leadership teams and executive boards with this week’s Movers & Shakers.
The new company is focused on tapping into the powers of the immune system to address numerous diseases.
Pharming Group N.V. announced that its Chief Financial Officer, Robin Wright, has decided not to put himself up for re-election as a member of the Board of Management and thus as Chief Financial Officer at the upcoming General Meeting of Shareholders on 20 May 2020 and that, as result of this decision, his term with the Company will end as at that date..
Cell Medica has rebranded itself as Kuur Therapeutics as it dives into the development of anti-cancer therapies using its innovative chimeric antigen receptor natural killer T cell therapy platform.
Numerous organizations are cancelling or postponing activities that involve large groups of people.
Mergers and acquisitions in the pharmaceutical industry are not only a positive for the company that has made a bid for another company, but it is also good for the industry as a whole because of increases in efficiency across the entire field.
PRESS RELEASES